New York State Common Retirement Fund Acquires 60,077 Shares of HealthEquity, Inc. (NASDAQ:HQY)

New York State Common Retirement Fund lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 142.6% in the 4th quarter, Holdings Channel reports. The firm owned 102,200 shares of the company’s stock after buying an additional 60,077 shares during the quarter. New York State Common Retirement Fund’s holdings in HealthEquity were worth $9,806,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of HQY. Holocene Advisors LP acquired a new stake in shares of HealthEquity in the third quarter worth about $1,246,000. GSA Capital Partners LLP bought a new position in shares of HealthEquity in the 3rd quarter valued at approximately $638,000. Natixis Advisors LLC lifted its holdings in HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after purchasing an additional 48,009 shares during the last quarter. Vaughan Nelson Investment Management L.P. boosted its position in HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the period. Finally, Loomis Sayles & Co. L P grew its holdings in HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after purchasing an additional 24,665 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Down 1.8 %

HQY stock opened at $107.45 on Wednesday. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $9.31 billion, a PE ratio of 98.58, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. The business’s 50-day simple moving average is $104.31 and its 200 day simple moving average is $92.89.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business earned $0.40 earnings per share. On average, research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Activity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now directly owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 39,000 shares of company stock worth $3,895,788. Corporate insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

HQY has been the subject of a number of analyst reports. Raymond James boosted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities upped their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Finally, Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $112.38.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.